메뉴 건너뛰기
Neurology
Volumn 77, Issue 8, 2011, Pages 803-804
The paradoxical effect of bevacizumab in the therapy of malignant gliomas
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; TUMOR MARKER; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;
EID: 80054040455     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182247068     Document Type: Letter
Times cited : (3)
References (8)
  • 1
    • 78751620483 scopus 로고    scopus 로고
    • The paradoxical effect of bevacizumab in the therapy of malignant gliomas
    • Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology 2011;76:87-93.
    • (2011) Neurology , vol.76 , pp. 87-93
    • Thompson, E.M.1    Frenkel, E.P.2    Neuwelt, E.A.3
  • 2
    • 38349135709 scopus 로고    scopus 로고
    • Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
    • Ches A, Wesseling P, Jeukin J, Maas C, Heerchap A, Leenders WO. Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization. Molec Cancer Ther 2008;7:71-78.
    • (2008) Molec Cancer Ther , vol.7 , pp. 71-78
    • Ches, A.1    Wesseling, P.2    Jeukin, J.3    Maas, C.4    Heerchap, A.5    Leenders, W.O.6
  • 3
    • 78651322039 scopus 로고    scopus 로고
    • Radiographic patterns of relapse in glioblastoma
    • Chamberlain MC. Radiographic patterns of relapse in glioblastoma. J Neuro-Oncol 2011;101:319-325.
    • (2011) J Neuro-Oncol , vol.101 , pp. 319-325
    • Chamberlain, M.C.1
  • 4
    • 33846955124 scopus 로고    scopus 로고
    • Early necrosis following temodar and radiotherapy in patients with glioblastoma
    • Chamberlain MC, Glantz MJ, Chalmers L, Sloan A. Early necrosis following temodar and radiotherapy in patients with glioblastoma. J Neuro-Oncol 2007;82:81-83.
    • (2007) J Neuro-Oncol , vol.82 , pp. 81-83
    • Chamberlain, M.C.1    Glantz, M.J.2    Chalmers, L.3    Sloan, A.4
  • 5
    • 79951984402 scopus 로고    scopus 로고
    • Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme
    • Lai A, Tran A, Nghiemphu P, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2011;29:142-148.
    • (2011) J Clin Oncol , vol.29 , pp. 142-148
    • Lai, A.1    Tran, A.2    Nghiemphu, P.3
  • 6
    • 65949103172 scopus 로고    scopus 로고
    • Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model
    • Jahnke K, Muldoon LL, Varallyay CG, et al. Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model. Neuro Oncol 2009;11:142-150.
    • (2009) Neuro Oncol , vol.11 , pp. 142-150
    • Jahnke, K.1    Muldoon, L.L.2    Varallyay, C.G.3
  • 7
    • 77952309402 scopus 로고    scopus 로고
    • Tumor invasion after treatment of glioblastoma with bevacizumab: Radiographic and pathologic correlation in humans and mice
    • de Groot JF, Fuller G, Kumar AJ, et al. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro-Oncol 2010;12:233-242.
    • (2010) Neuro-Oncol , vol.12 , pp. 233-242
    • De Groot, J.F.1    Fuller, G.2    Kumar, A.J.3
  • 8
    • 73849129203 scopus 로고    scopus 로고
    • Realtime imaging reveals the single steps of brain metastasis formation
    • Kienast Y, von Baumgarten L, Fuhrmann M, et al. Realtime imaging reveals the single steps of brain metastasis formation. Nat Med 2010;16:116-122.
    • (2010) Nat Med , vol.16 , pp. 116-122
    • Kienast, Y.1    Von Baumgarten, L.2    Fuhrmann, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.